Browse the evidence

The global rise in excess body weight, defined as BMI ≥ 25 kg/m², has led to a more than 6-fold increase in the number of obese adults (from 100 million to 671 million) between 1975 and 2016, driven by changes in the global food system and reduced physical activity.

The environment around you is designed to promote weight gain through easy access to cheap, energy-dense food and less physical activity. Recognizing this external pressure helps remove shame and shifts the focus to actionable strategies: choosing nutrient-dense foods and finding ways to move more, even in sedentary environments.

Current use of oral estrogen increases the risk of venous thromboembolism in postmenopausal women, with the highest risk occurring during the first year of treatment.

If you are a postmenopausal woman considering hormone replacement therapy, be aware that taking estrogen orally increases your risk of blood clots (venous thromboembolism), especially during the first year of use. This risk is roughly 2.5 times higher than in non-users. However, using estrogen through the skin (transdermal patches/gels) does not appear to increase this clotting risk, making it a potentially safer option to discuss with your doctor.

Accelerated biological aging of specific organs, measured via plasma proteomic signatures, significantly increases the risk of organ-specific diseases and all-cause mortality, independent of chronological age.

Your chronological age is not your biological destiny. This research shows that your organs age at different rates, and accelerated aging in specific organs (like the heart or brain) is a strong predictor of future disease and mortality, independent of how many birthdays you've had. While this specific test is not yet standard care, the key takeaway is that organ-specific health monitoring is crucial. Focus on maintaining the health of your most vulnerable organs through targeted lifestyle interventions, as organ-specific aging is a modifiable risk factor for major diseases like heart failure and Alzheimer's.

Central nervous system leptin signaling regulates energy balance and body weight primarily through the JAK-STAT3 pathway acting on hypothalamic neurons, specifically by activating pro-opiomelanocortin (POMC) neurons and inhibiting neuropeptide Y (NPY)/agouti-related protein (AgRP) neurons.

Your body produces leptin to signal fullness to your brain. In obesity, this signal often gets ignored (leptin resistance). Simply having high leptin doesn't fix this; the issue is how the brain processes the signal, not the amount of leptin itself.

Gestational diabetes mellitus (GDM) is the most prominent independent risk factor for the progression to type 2 diabetes in women, increasing the relative risk by approximately 8.3-fold.

If you had gestational diabetes, your risk of developing type 2 diabetes is over 8 times higher than women who did not. This risk persists for years. You need lifelong, regular glucose monitoring and lifestyle interventions, as standard postpartum care often neglects this long-term metabolic risk.

Obesity and type 2 diabetes share a pathogenesis involving nutrient excess, inflammation, and mitochondrial dysfunction, leading to insulin resistance and beta-cell failure.

Type 2 diabetes in obesity is driven by cellular stress from excess nutrients, causing inflammation and mitochondrial issues. Managing weight reduces this cellular stress, improving insulin sensitivity and beta-cell function.

Female age is a primary determinant of reproductive performance, with a significant decline in fertility starting in the mid-to-late 20s and a steep drop after age 35, affecting both natural conception and ART success rates.

If you are a woman planning to conceive, understand that fertility begins to decline in your late 20s and drops significantly after 35. This is a biological fact, not a lifestyle choice. If you are not ready to conceive by your early 30s, consider discussing egg freezing or other preservation options with a specialist, as waiting until 40 drastically reduces the chance of live birth via ART.

Leptin resistance, caused by defects in blood-brain barrier transport or intracellular signaling (e.g., SOCS3), is the primary driver of common obesity, whereas absolute leptin deficiency is rare.

In common obesity, your body produces plenty of leptin (the satiety hormone), but your brain stops listening to it. This 'leptin resistance' is a key biological barrier to weight loss.

Chronic low-grade inflammation (inflammaging) drives vascular aging by promoting oxidative stress, endothelial dysfunction, and atherosclerosis through the upregulation of cytokines like TNF-alpha and NF-kB activation.

Chronic, low-grade inflammation is a major driver of heart disease in older adults. It damages blood vessels by promoting oxidative stress and cell death. Managing inflammation through lifestyle factors is a key strategy for preventing age-related vascular disease.

In obese patients with type 2 diabetes, untreated obstructive sleep apnea (OSA) progresses rapidly, with AHI increasing by approximately 4 events per hour over one year even without weight gain.

If you have type 2 diabetes and sleep apnea, do not assume that staying at your current weight means your sleep apnea will stay stable. Without treatment or weight loss, your sleep apnea severity tends to worsen by about 4 events per hour each year. Early intervention is crucial to prevent this progression.

Roux-en-Y gastric bypass (RYGB) resolves type 2 diabetes mellitus in approximately 83% of cases, often within days of surgery, through mechanisms that improve insulin sensitivity and secretion independently of immediate weight loss.

If you have type 2 diabetes and undergo Roux-en-Y gastric bypass, expect a high likelihood of remission (approx. 83%), often occurring within days of surgery, long before you lose significant weight. This is driven by hormonal changes that improve insulin sensitivity and secretion. You may be able to discontinue diabetes medications quickly, but this requires close medical supervision.

Short-term dietary interventions cause rapid but transient fluctuations in the adult gut microbiome, which typically returns to its baseline stable state once the intervention ends.

Don't panic if your gut feels different after a few days of eating differently. In adults, the microbiome is resilient and will bounce back to its normal state once you return to your usual diet. To make lasting changes, you need to maintain new dietary habits for months or years, not just days.

Dietary intake of choline and L-carnitine leads to the gut microbial production of Trimethylamine (TMA), which is converted by host liver enzymes (FMO3) into Trimethylamine N-oxide (TMAO).

Eating foods rich in choline (eggs, meat) and carnitine (red meat) provides the raw materials for your gut bacteria to create TMA, which your liver turns into TMAO. This process is the primary way diet influences TMAO levels.

Familial Combined Hyperlipidemia (FCHL) is a common genetic subtype of the metabolic syndrome characterized by disproportionately elevated Apo B levels, which significantly increases the risk of premature coronary artery disease compared to the metabolic syndrome alone.

If you have metabolic syndrome, ask your doctor to check your Apo B levels. If they are high, you may have Familial Combined Hyperlipidemia (FCHL), a genetic condition that puts you at much higher risk for heart disease than metabolic syndrome alone. This diagnosis is crucial because it often requires more aggressive treatment, such as lipid-lowering therapy, to prevent heart attacks.

Measuring Apolipoprotein B (Apo B) is a superior predictor of cardiovascular risk compared to standard LDL cholesterol in patients with the metabolic syndrome, as it accurately reflects the total number of atherogenic particles.

Standard cholesterol tests measure the amount of cholesterol in LDL particles, not the number of particles. In metabolic syndrome, particles are small and dense, carrying less cholesterol but causing more damage. Asking for an Apo B test gives a more accurate count of these dangerous particles, helping your doctor decide if you need stronger medication to protect your heart.

Individual dietary choices are heavily influenced by complex factors beyond personal responsibility, including commercial pressures, sociocultural determinants, and the local food environment.

Understand that your food choices are not just about willpower. They are shaped by what is available, affordable, and marketed to you. Systemic change is needed to make healthy choices easier.

Leptin resistance, a primary risk factor for obesity, results from impaired leptin transport across the blood-brain barrier, defective LEPRb signaling (via SOCS3 and PTP1B), and disrupted hypothalamic neurocircuitry.

Obesity is not just about calories; it involves a broken hormonal signal (leptin) that fails to tell your brain to stop eating and burn fat. This failure happens due to transport issues, receptor signaling blocks (like SOCS3), and neural circuit changes. Treating obesity requires addressing these biological resistance mechanisms, not just willpower.

Leptin regulates energy balance primarily by acting on the hypothalamus (specifically ARC, VMH, PVH) to activate LEPRb, which triggers downstream pathways (STAT3, PI3K, MAPK) to suppress appetite and increase energy expenditure.

Your brain's hypothalamus is the control center for weight, using leptin signals to decide how much to eat and burn. This process relies on specific receptors (LEPRb) and signaling pathways (STAT3, PI3K) within the brain.

Subgroup analyses suggesting benefits from specific vitamins (e.g., Vitamin B6 for cardiovascular death, Vitamin E for myocardial infarction) were artifacts of trials funded or supplied by the pharmaceutical industry and disappeared in high-quality trials.

Be skeptical of claims that specific vitamins like B6 or E prevent heart attacks or death. This analysis shows these benefits only appear in studies funded or supplied by the pharmaceutical industry. When looking at high-quality, independent trials, these benefits disappear.

Obstructive Sleep Apnea is causally linked to the development of systemic hypertension, with worsening AHI independently associated with an increasing risk of new hypertension, even in mild cases.

Even mild sleep apnea can silently raise your risk of developing high blood pressure. If you have risk factors like obesity or snoring, getting screened for sleep apnea is important for your long-term heart health, regardless of whether you feel tired during the day.

Combining aerobic and resistance training (AT/RT) does not provide additive fat mass or body mass reduction benefits compared to aerobic training (AT) alone, despite requiring double the time commitment.

If you want to lose fat, you do not need to combine aerobic and resistance training. Aerobic exercise alone is just as effective for fat loss as doing both, but it takes half the time. Focus on aerobic exercise for fat loss, and add resistance training only if you specifically want to build muscle.

Adiposity signals (leptin and insulin) decline disproportionately to fat mass loss because smaller adipocytes secrete less leptin and are more insulin-sensitive, creating a persistent 'energy depletion' signal even when fat mass is stable.

Your body's 'fuel gauge' (leptin/insulin) reads lower than your actual fat mass suggests because your fat cells have shrunk. This tricks your brain into thinking you are starving, driving hunger and conserving energy. This is a normal physiological response to weight loss.

Total testosterone levels remain relatively stable until approximately age 55 in healthy nonobese men, after which they decline rapidly, while free testosterone declines linearly from a younger age.

For healthy men, Total Testosterone stays stable until about 55. If you are younger, low Total T might not be 'just aging.' However, Free Testosterone starts dropping earlier, so symptoms may appear before Total T drops significantly.

BMI is a poor index for assessing body composition and obesity risk in children because it does not distinguish between lean mass and fat mass.

Do not rely solely on BMI to assess body fatness, especially in children. It does not distinguish between muscle and fat. More sophisticated measures are needed for accurate assessment.